Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12

Our last raise in October 2020 ($55m at 17c) was completed when the company had ~$22m in the bank which at the time was enough to fund 6 quarters worth of expenditures.

Now we find ourselves with $11m in the bank and a runway to see us through only the next 2 quarters (excluding incentive to be received Q1 FY24) talk about cutting it fine.

The thought of issuing 1b shares to take us through phase 1 is enough to make one shudder but I just can't see management taking this route.

Something needs to eventuate at our around the BIO conference in June because the clock is ticking

Lets not forget, it's always darkest before the dawn

cheers